跳至主要内容
临床试验/NCT06524791
NCT06524791尚未招募不适用

Evaluation of the Prevalence of Faecal Bacteriophage Carriage in Patients With Digestive Symptoms.

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
300
试验地点
1
主要终点
prevalence of faecal phage carriage

研究概览

简要总结

Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture)

(ii) Determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection)

(iii) Explore factors that could impact fecal phage carriage (patients with digestive symptoms vs. healthy individuals, immunocompromised patients vs. immunocompetent patients)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18 and
  • Persons having developed gastrointestinal symptoms justifying microbiological stool testing at the time of hospitalization.
  • Person having received full information on the organization of the research and not having objected to the use of this data

排除标准

  • Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the French Public Health Code.
  • Pregnant or breast-feeding women,
  • Minors (not emancipated),
  • Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice),
  • Persons of full age who are unable to give their consent.
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1.

结局指标

主要结局

prevalence of faecal phage carriage

时间窗: baseline

define the prevalence of faecal phage (coliphage) carriage in individuals presenting with digestive symptoms.

次要结局

  • concentrations of infectious fecal phages(baseline)
  • fecal phage genome concentrations(baseline)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

HARTARD Cédric

Principal Investigator

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验